What is MBX Biosciences, Inc.'s redeemable NCI?

MBX Biosciences, Inc. (MBX) reported redeemable NCI of $0 in Q4 2024.

What does redeemable NCI mean?

Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.

BridgeBio PharmaBBIO

——

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Market cap$2.21B+475%

Enterprise value$2.16B+533%

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityPreferredCarryingAmount.

The official record: MBX Biosciences, Inc.’s 10-K, filed March 17, 2025, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is MBX Biosciences, Inc.'s redeemable NCI?: MBX Biosciences, Inc. (MBX) reported redeemable NCI of $0 in Q4 2024.
What does redeemable NCI mean?: Minority interests in subsidiaries that include a put option allowing the minority holder to require the parent to repurchase their stake.